国家/地区 中国（5）
IPC部 A（5）
IPC大类 A61（5） A01（2） C01（2）
IPC小类 A61K（5） A61P（5） A01N（2）
A01P（2） A61Q（2） C01B（2）
IPC A61K033/44（5）
发明人
公开年 2021（4）
申请年 2021（5）
专利权人

Use of two-dimensional nanomaterial in preparing medicine for treating or preventing diseases caused by coronavirus by inhibiting binding of coronavirus spike protein to receptor angiotensin-converting enzyme 2 (ACE2) of its host cells.

LI Y, WANG L, ZHANG G

Preparing graphene oxide-based nitrogen triacetic acid-cerium complex useful for removing infectious film in animal body, comprises e.g. reacting graphene oxide with nitrotriacetic acid to be carboxylated, and then combining with cerium ions.

WU L, HU H, KANG X, JI H

Graphene quantum dot used for preparing formulation, fiber product or in vivo implant for providing antibacterial effect, is prepared by mixing trinitrorylene with o-phenylenediamine, adding water and sodium hydroxide to obtain reaction system, uniformly mixing and performing hydrothermal reaction.

SHAN J, OU L, WU Z, XIA W, QI L

Virus-shaped silicon dioxide-graphene composite material useful in multi-stage programmed wound healing repair agent, comprises virus-shaped silicon dioxide nanoparticle suspension and graphene solution, where virus-shaped silicon dioxide is aminated.

WANG J, NING X, CAO J, FENG Y

Use of graphene oxide or its regulatory molecules for use in preparation of drugs for inhibiting apoptosis of Ad-MSCs induced by high glucose, preferably regulatory molecule of graphene oxide is Linc 00324.

JIN P, LI Q, ZHANG A, JI Z, LI X, SHEN C, GUO L